Twinstrand Therapeutics Inc.
THE COMPANY
Twinstrand is a privately-owned biopharmaceutical company
incorporated under the laws of Canada. The company is a spin-
off from Simon Fraser University's Institute of Molecular
Biology and Biochemistry. It specializes in the development of
recombinant DNA products for the treatment of human disease.
Twinstrand currently has a technical/scientific staff of 17 and
occupies modern laboratory and office space in Burnaby, British
Columbia, a suburb of Vancouver.
DEVELOPMENT PLANS
Cancer will serve as first proof of the targeting concept. The
company anticipates having a molecule for this disease in
clinical trials by 2003. Twinstrand intends to complete
preclinical development and fund clinical trials through a
combination of equity financing and joint venturing/licencing
with outside organisations. The company seeks partners for
clinical development in all therapeutic areas.
Company Details
Year Established:
1995
Number of Employees:
20
Company Information
Thor Borgford
Title:
President
Area of Responsibility:
Management Executive
Telephone:
(604) 415-7180
Fax:
(604) 415-7185
Email:
Click Here
Curtis Braun
Title:
Chief Operating Officer
Area of Responsibility:
Manufacturing/Production/Operations
Telephone:
(604) 415-7180
Fax:
(604) 415-7185
Email:
Click Here
Products
Enzyme-toxin Therapeutic
Non-invasive Diagnostic
Under development - test used in the detection of gastric damage
(i.e. ulcers)
Services
Biotechnology